Valuation: Philadelphia Pharmaceuticals Company

Market Cap 14.85M 20.98M 18.35M 16.96M 15.6M 29.43M 2.02B 30.11M 202M 79.52M 990M 78.79M 77.05M 3.41B P/E 2024
13.7x
P/E 2025 11.9x
Enterprise Value 14.78M 20.88M 18.27M 16.88M 15.53M 29.3M 2.01B 29.97M 201M 79.16M 985M 78.43M 76.7M 3.39B EV / Sales 2024
1.32x
EV / Sales 2025 1.3x
Free-Float
7.27%
Yield 2024
4.67%
Yield 2025 -
1 day+5.32%
1 week+18.56%
Current month+18.56%
1 month+18.56%
3 months+32.00%
6 months+25.32%
Current year+23.75%
1 week 1.76
Extreme 1.76
1.98
1 month 1.71
Extreme 1.71
1.98
Current year 1.5
Extreme 1.5
1.98
1 year 1.46
Extreme 1.46
1.98
3 years 1.34
Extreme 1.34
1.98
5 years 1.28
Extreme 1.28
1.98
10 years 1.28
Extreme 1.28
3.42
Manager TitleAgeSince
Chief Executive Officer 44 31/12/2012
Chief Tech/Sci/R&D Officer - -
Director of Finance/CFO 50 31/12/2001
Director TitleAgeSince
Chairman 58 -
Director/Board Member 61 31/08/2016
Director/Board Member 64 31/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
+5.32%+18.56%+33.78%+46.67% 20.95M
-0.90%-0.15%+14.11%+81.10% 48.15B
-0.23%-1.65%+67.15%+112.03% 35.59B
-0.76%-1.44%-4.29%+37.63% 11.9B
-0.88%-0.62%+17.31%+89.97% 11.85B
+0.19%+2.87%+34.92%+139.73% 9.31B
+3.37%-0.10%+51.64%-3.75% 7.02B
-0.75%-0.91%+17.45%+37.70% 6.91B
-2.25%-2.08%+0.45%+209.99% 6.55B
-9.93%+0.35%-31.51%+16.58% 6.13B
Average -0.68%+1.84%+20.10%+76.76% 14.34B
Weighted average by Cap. -0.88%-0.42%+26.79%+86.59%

Financials

2024 2025
Net sales 8.76M 12.38M 10.83M 10.01M 9.2M 17.37M 1.19B 17.77M 119M 46.92M 584M 46.49M 45.47M 2.01B 9.17M 12.95M 11.33M 10.47M 9.63M 18.17M 1.25B 18.59M 125M 49.1M 611M 48.65M 47.58M 2.11B
Net income 822K 1.16M 1.02M 938K 863K 1.63M 112M 1.67M 11.19M 4.4M 54.75M 4.36M 4.26M 189M 1.01M 1.42M 1.24M 1.15M 1.06M 1.99M 137M 2.04M 13.69M 5.38M 66.98M 5.33M 5.22M 231M
Net Debt 334K 471K 412K 381K 350K 661K 45.38M 676K 4.54M 1.79M 22.23M 1.77M 1.73M 76.61M -67.69K -95.63K -83.64K -77.28K -71.09K -134K -9.21M -137K -922K -362K -4.51M -359K -351K -15.54M
Logo Philadelphia Pharmaceuticals Company
Philadelphia Pharmaceuticals Industry Company PSC is a Jordan-based company that is engaged in the development, manufacture and marketing of human pharmaceutical products of different therapeutic categories. The Company, through its production facilities and laboratories located in Amman Industrial state, develops and produces a number of products that includes: Semisolid Dosage Forms, such as creams, ointments, lotions, gels and suppositories, as well as Liquid Dosage Forms, which include syrups, suspensions, solutions, nasal, drops, mouth washes and vaginal douches. Furthermore, the Company undertakes the distribution and marketing of a range of healthcare systems, miscellaneous and pharmaceuticals of different international brand names, including alimentary, gastrointestinal systems and respiratory systems. The Company markets its products to the local markets and exports to more than 10 countries in the Middle East and North Africa region.
Employees
129
Date Price Change Volume
16/07/26 JOD 1.980 +5.32% 6
15/07/26 JOD 1.880 +7.43% 1,721
  1. Stock Market
  2. Stocks
  3. PHIL Stock